Press Release Details

View all news

Quest Diagnostics Pathologist Ronald D. Luff, MD Elected President Of American Society of Cytopathology


TETERBORO, N.J., May 15, 2000 —

Ronald D. Luff, M.D. has been elected to serve as President of the American Society of Cytopathology for 2000. Dr. Luff is the Director of Anatomic Pathology for the Teterboro laboratory of Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of clinical laboratory testing, information and services.

As the 48th President of the Society, Dr. Luff will lead the organization during 2000 and will preside over its next Annual Scientific Meeting in Philadelphia in November 2000. Based in Wilmington, Del., the American Society of Cytopathology (ASC), founded in 1951, is a distinguished national professional society of physicians, cytotechnologists and scientists who are dedicated to the cytologic method of diagnostic pathology, which involves evaluating cells with a microscope for abnormalities.

In addition to providing medical and administrative leadership as Director of Anatomic Pathology for Quest Diagnostics’ Teterboro laboratory, Dr. Luff also serves as Clinical Professor and Medical Director of the Program in Cytotechnology at Thomas Jefferson University in Philadelphia. He is a Colonel in the United States Air Force (Retired Reserve) with affiliation as Visiting Scientist at the Armed Forces Institute of Pathology in Washington, D.C. He also serves as a Consultant Pathologist to the Department of Pathology at Sacred Heart Hospital in Allentown, PA., and to various governmental agencies, including the Pennsylvania Department of Health and the U.S. Centers for Disease Control and Prevention and the Health Care Financing Administration.

As Chairman of the Editorial Committee for The Bethesda System, Dr. Luff played an instrumental role in establishing the first nationwide system to standardize the terminology used in diagnosis and treatment of cervical disease. The Bethesda System grew out of workshops first sponsored by the National Cancer Institute in the late 1980s.

Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services with annualized revenues of more than $3 billion. The testing performed on human specimens helps doctors diagnose, treat and monitor disease; enables employers to detect workplace drug abuse; and supports pharmaceutical and biotechnology companies in clinical trials of new therapeutics worldwide. Quest Informatics analyzes laboratory and other medical data to help health care providers improve the care of patients. Additional company information can be found on the Internet at:

# # #

Categories: Press Releases
View all news